ModernaLIM:MRNA 48 OCF Margin % is -161.95% as of Mar. 2026. GuruFocus rates LIM:MRNA with a GF Score™ of 48/100 and a GF Value™ of $17.46 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Moderna ranks worse than 50.05% on this metric.
The historical rank and industry rank for Moderna's OCF Margin % or its related term are showing as below:
LIM:MRNA'
s OCF Margin % Range Over the Past 10 Years
Min: -956.25 Med: -70.04 Max: 739.78
Current: -66.52
During the past 10 years, the highest OCF Margin % of Moderna was 739.78%. The lowest was -956.25%. And the median was -70.04%.
LIM:MRNA's OCF Margin % is ranked worse than 50.05% of 959
companies
in the Biotechnology industry
Industry Median: -66.52
vs LIM:MRNA: -66.52
Moderna OCF Margin % Related Terms
Moderna OCF Margin % Historical Data
* Premium members only.
The historical data trend for Moderna's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LIM:MRNA vs INCY, ROIV, JAZZ: OCF Margin % Comparison
For the Biotechnology subindustry, Moderna's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moderna OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moderna's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Moderna's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moderna (LIM:MRNA) has a OCF Margin % of -161.95% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Moderna and its competitors. According to the industry distribution chart, Moderna ranks #480 out of 959 companies in the Biotechnology industry, placing it in the top 50.1%.
Is Moderna's OCF Margin % too high?
Moderna's current OCF Margin % is -161.95%. Based on the distribution chart, Moderna ranks #480 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Moderna has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Moderna's OCF Margin % compare to INCY and ROIV?
According to the Biotechnology industry distribution chart, Moderna ranks #480 out of 959 companies for OCF Margin %. This places Moderna in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Moderna and its competitors. Moderna's current OCF Margin % is -161.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Based on GuruFocus' analysis, Moderna (LIM:MRNA) is currently considered Significantly Overvalued. The stock's GF Value™ is $17.46, compared to a current price of $46.40 — trading 165.8% above its estimated fair value. The current OCF Margin % is -161.95%. Moderna's overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Moderna (LIM:MRNA), the current OCF Margin % is -161.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moderna (LIM:MRNA) Overvalued in 2026?
Based on GuruFocus' analysis, Moderna stock appears to be overvalued.
The current stock price of $46.40 is trading 165.8% above its estimated GF Value™ of $17.46.
GuruFocus considers Moderna to be Significantly Overvalued.
Key valuation signals for LIM:MRNA:
OCF Margin %: -161.95%
GF Value™: $17.46 vs. price of $46.40 (165.8% above fair value)
No single metric tells the full story. See the LIM:MRNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
48GF Score
Get the complete analysis for LIM:MRNA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LIM:MRNA has been successfully added to your 
